Ocular Therapeutix Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.5% | 24.9% | 24.2% | 23.7% | 23.9% | 23.2% | 23.5% | 23.6% | 23.1% | 23.2% | 26.0% | 84.9% | 97.2% | 37.2% | 31.4% | 8.5% | 7.7% | 9.3% | 12.1% | 9.4% | 10.8% | 9.0% | 9.9% | 9.4% | 9.0% | 7.2% | 9.1% | 8.6% | 9.1% | 9.4% | 9.0% | 9.2% | 10.1% | 7.2% | 11.8% | 14.4% | 12.2% | 12.0% | 12.3% | 14.9% | 12.9% | |
| 76.5% | 75.1% | 75.8% | 76.3% | 76.1% | 76.8% | 76.5% | 76.4% | 76.9% | 76.8% | 74.0% | 15.1% | 2.8% | 62.8% | 68.6% | 91.5% | 92.3% | 90.7% | 87.9% | 90.6% | 89.2% | 91.0% | 90.1% | 90.6% | 91.0% | 92.8% | 90.9% | 91.4% | 90.9% | 90.6% | 91.0% | 90.8% | 89.9% | 92.8% | 88.2% | 85.6% | 87.8% | 88.0% | 87.7% | 85.1% | 87.1% | |
| 1,192.0% | 1,434.1% | 1,416.6% | 1,853.2% | 1,553.7% | 1,623.8% | 2,419.7% | 1,349.5% | 1,944.8% | 2,035.3% | 2,300.2% | 1,448.3% | 1,234.6% | 448.8% | 233.7% | 511.2% | 118.3% | 103.7% | 148.8% | 118.3% | 104.7% | 102.2% | 99.3% | 106.8% | 114.7% | 96.2% | 110.3% | 99.4% | 99.6% | 109.4% | 140.3% | 175.5% | 240.2% | 240.0% | 400.6% | 379.5% | 360.0% | 383.4% | 613.9% | 401.8% | 429.4% | |
| 549.9% | 587.5% | 689.7% | 850.2% | 808.8% | 878.6% | 1,403.2% | 686.3% | 893.0% | 1,016.1% | 1,089.0% | 778.2% | 742.5% | 246.1% | 198.4% | 327.9% | 101.4% | 89.5% | 104.4% | 73.4% | 66.5% | 61.2% | 57.3% | 63.5% | 71.3% | 59.3% | 140.3% | 54.0% | 112.0% | 295.6% | 156.1% | 119.6% | 79.3% | 141.2% | 270.5% | 197.3% | 110.2% | 133.3% | 185.5% | 164.4% | 145.7% | |
| 2,013.2% | 2,515.9% | 3,375.2% | 4,263.2% | 2,981.6% | 2,687.9% | 4,033.8% | 2,169.6% | 3,052.0% | 3,506.0% | 4,069.5% | 3,338.0% | 2,794.6% | 1,011.4% | 705.4% | 1,231.3% | 330.7% | 285.9% | 363.4% | 263.3% | 249.9% | 237.6% | 225.4% | 253.0% | 271.1% | 230.4% | 259.5% | 226.9% | 218.3% | 226.1% | 305.0% | 356.0% | 388.1% | 388.9% | 685.7% | 588.1% | 560.1% | 614.5% | 953.1% | 694.4% | 690.2% | |
| -1,936.7% | -2,440.7% | -3,299.4% | -4,187.0% | -2,905.5% | -2,611.1% | -3,957.4% | -2,093.2% | -2,975.1% | -3,429.2% | -3,995.5% | -3,322.9% | -2,791.8% | -948.6% | -636.8% | -1,139.8% | -238.4% | -195.2% | -275.5% | -172.6% | -160.7% | -146.6% | -135.2% | -162.4% | -180.1% | -137.6% | -168.6% | -135.5% | -127.4% | -135.5% | -214.0% | -265.1% | -298.2% | -296.1% | -597.5% | -502.6% | -472.3% | -526.5% | -865.5% | -609.3% | -603.0% | |
| 89.3% | 81.8% | 93.3% | 106.8% | 93.9% | 100.6% | 142.9% | 70.2% | 85.1% | 74.2% | 206.9% | 250.3% | 199.2% | 80.0% | 62.6% | 108.0% | 29.2% | 23.5% | 22.9% | 14.1% | 13.6% | 13.6% | 12.8% | 13.8% | 15.0% | 13.1% | 13.2% | 13.1% | 22.7% | 28.0% | 27.4% | 19.4% | 20.9% | 18.2% | 27.9% | 22.4% | 20.6% | 21.4% | 25.7% | 20.7% | 21.9% | |
| -2,011.7% | -2,509.2% | -3,373.3% | -4,268.0% | -2,976.5% | -2,690.3% | -4,048.5% | -2,130.2% | -3,014.1% | -3,452.2% | -3,480.5% | -3,762.0% | -2,265.1% | -1,153.2% | -824.5% | -2,330.7% | -203.3% | -1,164.9% | 42.5% | -72.4% | 21.9% | -31.3% | -95.1% | -153.0% | -202.2% | -110.4% | -226.7% | -136.2% | -3.4% | -197.4% | -438.9% | -266.3% | -236.6% | -283.3% | -598.7% | -503.9% | -477.3% | -488.0% | -821.6% | -584.5% | -579.1% | |
| 89.1% | -36.2% | 19.4% | 25.8% | 94.8% | -87.1% | 51.8% | 33.2% | 46.2% | -64.3% | 206.9% | 250.3% | 198.2% | 50.1% | 62.6% | 108.0% | 29.2% | 14.4% | 22.9% | 14.1% | 13.6% | 13.6% | -40.1% | -9.4% | 22.1% | -27.1% | 45.5% | 13.1% | -5.9% | -48.5% | -6.2% | – | – | – | – | – | – | – | – | – | – | |
| -2,011.7% | -2,509.2% | -3,373.3% | -4,268.0% | -2,976.5% | -2,690.3% | -4,048.5% | -2,130.2% | -3,014.1% | -3,452.2% | -3,480.5% | -3,762.0% | -2,265.1% | -1,153.2% | -824.5% | -2,330.7% | -203.3% | -1,164.9% | 42.5% | -72.4% | 21.9% | -31.3% | -95.1% | -153.0% | -202.2% | -110.4% | -226.7% | -136.2% | -3.4% | -197.4% | -438.9% | -266.3% | -236.6% | -283.3% | -598.7% | -503.9% | -477.3% | -488.0% | -821.6% | -584.5% | -579.1% | |
| -1,877.1% | -2,377.9% | -3,225.1% | -4,080.4% | -2,790.4% | -2,481.3% | -3,739.4% | -1,972.7% | -2,813.9% | -3,262.5% | -3,115.9% | -3,448.5% | -1,985.3% | -1,043.4% | -733.8% | -2,177.6% | -162.8% | -1,132.4% | 74.2% | -53.0% | 40.4% | -13.0% | -78.1% | -134.7% | -182.9% | -93.8% | -209.9% | -118.8% | 25.2% | -162.9% | -405.3% | -241.0% | -209.5% | -259.5% | -561.7% | -473.8% | -449.3% | -457.2% | -784.0% | -550.1% | -546.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.